// App-Quantinova.ai

e11501 : Cardiac outcomes in women receiving aromatase inhibitors as adjuvant endocrine therapy for breast cancer.

Researchers

Presenter

  • Esther Park

Principal Investigators

  • Maysa M. Abu-Khalaf

  • Erin Wysong Hofstatter

  • Tara Beth Sanft

  • Raymond Russell

  • Christos Hatzis

  • Johanna M. Silber

Medical Centers

  • Yale Cancer Center, Yale School of Medicine, New Haven, CT

  • Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CTYale School of Medicine, New Haven, CT

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myocardial infarction

  • Myocardial ischemia

  • Breast cancer

  • Coronary Artery Disease

  • Solid malignancies

Biomarkers

  • Body mass index

Drug/Treatment

  • Tamoxifen

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved